Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CNR2 | P34972 | 17/20 | 0.35 |
| ▸ | CNR1 | P21554 | 9/20 | 0.35 |
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4018062 | 0.94 | CNR2 (0.33) | CNR2CNR1GAA | |
| SCHEMBL4012322 | 0.88 | LMNA (0.33) | NPC1SMN1; SMN2LMNAGAA | |
| SCHEMBL4013326 | 0.77 | CNR2 (0.44) | CNR2CNR1NPC1SMN1; SMN2GAA | |
| SCHEMBL1619477 | 0.74 | CNR2 (0.55) | CNR2CNR1NPC1SMN1; SMN2LMNA | |
| SCHEMBL1620926 | 0.74 | CNR2 (0.55) | CNR2CNR1NPC1SMN1; SMN2LMNA | |
| SCHEMBL1620543 | 0.73 | CNR2 (0.56) | CNR2CNR1NPC1SMN1; SMN2LMNA | |
| SCHEMBL1621013 | 0.72 | HPGD (0.51) | CNR2CNR1NPC1SMN1; SMN2LMNA | |
| SCHEMBL4017977 | 0.71 | CNR2 (0.46) | CNR2CNR1 | |
| SCHEMBL1620953 | 0.71 | KMT2A (0.46) | CNR2CNR1NPC1SMN1; SMN2LMNA | |
| SCHEMBL1620892 | 0.70 | CNR2 (0.58) | CNR2CNR1NPC1SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2074084-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | Boehringer Ingelheim International GmbH (DE) | 2009-07-01 | — | — | EP | claimed |
| WO-2008039645-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-04-03 | — | — | WO | claimed |
| EP-2074084-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | Boehringer Ingelheim International GmbH (DE) | 2009-07-01 | — | — | EP | disclosed |
| WO-2008039645-A1 | COMPOUNDS WHICH MODULATE THE CB2 RECEPTOR | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2008-04-03 | — | — | WO | disclosed |